With respect to complex cross-border projects we provide our expertise to German companies in France, French companies in Germany as well as to German-French companies worldwide.
Latest news & insights
Hamburg Regional Court: validity of the presumption of availability in maintenance contracts
#7: State of the EU Crypto Industry: MiCA, Tokenisation and What Comes Next
Online coaching and distance learning: Federal Court of Justice clarifies application of the Distance Learning Protection Act
by multiple authors
Impact of the new Biotech Act on Clinical Trials in the EU
A European Perspective #1 | EU Biotech Act: Faster Clinical Trial Approvals Ahead | The European Commission’s proposed Biotech Act aims to streamline clinical trial procedures, shorten approval timelines, and harmonise data protection rules across the EU. If adopted, the reform could significantly accelerate multinational clinical research in the EU.
by Irina Rebin
4 of 9 Insights
The 2026 Pharma Package: A New Regulatory Framework for Medicinal Products in the EU
A European Perspective #1 | The EU’s largest pharmaceutical law reform in over 20 years introduces a new regulatory exclusivity framework, revised orphan drug incentives and an antimicrobial voucher. Strategic exclusivity planning will become essential for pharmaceutical companies.
by Irina Rebin
1 of 9 Insights